Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.69 |
| ▸ | RECQL | P46063 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.63 |
| ▸ | HRH1 | P35367 | 1/20 | 0.63 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | CPT2 | P23786 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16238330 | 0.93 | MEN1 (0.73) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL19655965 | 0.88 | MEN1 (0.65) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL21594797 | 0.88 | MEN1 (0.65) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL464880 | 0.87 | MEN1 (0.73) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL232682 | 0.87 | MEN1 (0.73) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL28369484 | 0.86 | MEN1 (0.68) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| Hydrochloric Acid SCHEMBL9465317 | 0.85 | MEN1 (0.71) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL30513874 | 0.85 | MEN1 (0.71) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL31011113 | 0.85 | MEN1 (0.71) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL288495 | 0.85 | MEN1 (0.71) | MEN1KMT2ACYP2C19RECQLCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4515242-A1 | METABOLITE PREDICTORS FOR LUNG CANCER | JANSSEN Pharmaceutica NV (BE) | 2025-03-05 | — | — | EP | claimed |
| CN-119534850-A | Marker group capable of reflecting prolongation of post-PCI proinflammatory period of ACS patient and application thereof | 天津中医药大学 | 2025-02-28 | — | — | CN | claimed |
| US-20240230622-A9 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-07-11 | — | — | US | claimed |
| US-20240133865-A1 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-04-25 | — | — | US | claimed |
| WO-2023209218-A1 | METABOLITE PREDICTORS FOR LUNG CANCER | JANSSEN PHARMACEUTICA NV (BE) | 2023-11-02 | — | — | WO | claimed |
| US-11674948-B2 | Methods and systems for determining autism spectrum disorder risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2023-06-13 | — | — | US | claimed |
| EP-3954991-A2 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | Laboratory Corporation of America Holdings (US) | 2022-02-16 | — | — | EP | claimed |
| CN-113009122-A | Methods and systems for determining risk of autism spectrum disorders | 美国控股实验室公司 | 2021-06-22 | — | — | CN | claimed |
| EP-3151665-B1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORP AMERICA HOLDINGS (US) | 2021-03-10 | — | — | EP | claimed |
| CN-106714556-B | Methods and systems for determining risk of autism spectrum disorders | 美国控股实验室公司 | 2021-01-26 | — | — | CN | claimed |
| US-20160116486-A1 | BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME | METABOLON, INC. | 2016-04-28 | — | — | US | claimed |
| US-20160091481-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2016-03-31 | — | — | US | claimed |
| US-20160091480-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2016-03-31 | — | — | US | claimed |
| US-9176113-B1 | Methods and systems for determining autism spectrum disorder risk | SYNAPDX CORPORATION (US) | 2015-11-03 | — | — | US | claimed |
| US-20150293072-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2015-10-15 | — | — | US | claimed |
| WO-2015157601-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | SYNAPDX CORPORATION (US) | 2015-10-15 | — | — | WO | claimed |
| US-20150294081-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2015-10-15 | — | — | US | claimed |
| WO-2013188333-A1 | BIOMARKERS RELATED TO NEPHROTOXICITY AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-12-19 | — | — | WO | claimed |
| WO-2012164525-A2 | AGING BIOMARKERS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2012-12-06 | — | — | WO | claimed |
| US-7229834-B2 | Diagnosing carnitine deficiency in patients, monitoring by blood analyzing, mass-spectrometry method | PEDIATRIX SCREENING, INC. (US) | 2007-06-12 | — | — | US | claimed |